Neuphoria Therapeutics Income Statement (2020-2026) | NEUP

Income Statement Jun2020 Jun2021 Dec2021 Jun2022 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026
Revenue & cost
Revenue (Quarter) 0.66M15.00M-0.01M
Operating items
Research & Development (Quarter) 3.09M2.03M1.20M3.10M1.90M1.74M1.62M3.75M3.79M0.70M
Selling, General & Administrative (Quarter) 2.38M2.52M1.20M2.38M1.67M2.63M1.41M2.07M1.87M2.13M1.69M
Other Operating Expenses (Quarter) 1.24M-0.48M
Operating Expenses (Quarter) 5.47M4.55M2.39M5.48M3.57M4.37M3.02M5.82M5.65M4.06M1.21M
Operating Income (Quarter) -5.47M-4.55M-2.39M8.52M-3.57M-3.70M11.98M-4.88M-5.65M-4.06M-1.21M
EBIT (Quarter) -5.47M-4.55M-2.39M8.52M-3.57M-3.70M11.98M-4.88M-5.65M-4.06M-1.21M
Non-operating items
Interest & Investment Income (Quarter) 0.09M0.05M0.05M0.03M0.04M0.03M0.01M0.09M0.14M0.17M0.19M
Other Non Operating Income (Quarter) -0.12M0.18M0.22M2.36M-0.28M0.63M0.17M-0.94M-0.06M-0.14M-0.29M
Non Operating Income (Quarter) -0.04M-0.04M-0.37M0.40M2.63M1.77M-0.80M-3.51M-4.29M5.89M0.67M
Net income details
EBT (Quarter) -5.51M-4.59M-2.76M-0.90M-0.94M-1.93M11.18M-9.15M-9.94M1.83M-0.54M
Tax Provisions (Quarter) -0.03M-0.03M0.02M-0.03M-0.13M0.01M-0.08M0.20M-0.03M-0.03M-0.03M
Profit After Tax (Quarter) -5.47M-4.55M-2.78M-2.69M-0.80M-1.90M11.30M-8.90M-9.91M1.86M-0.50M
Income from Continuing Operations (Quarter) -5.47M-4.55M-2.78M-0.87M-0.80M-1.94M11.26M-9.35M-9.91M1.86M-0.51M
Consolidated Net Income (Quarter) -5.47M-4.55M-2.78M-0.87M-0.80M-1.94M11.26M-9.35M-9.91M1.86M-0.51M
Income towards Parent Company (Quarter) -5.47M-4.55M-2.78M-0.87M-0.80M-1.94M11.26M-9.35M-9.91M1.86M-0.51M
Net Income towards Common Stockholders (Quarter) -5.47M-4.55M-2.78M-0.87M-0.80M-1.94M11.26M-9.35M-9.91M1.86M-0.51M
Additional items
EPS (Basic) (Quarter) 0.00-5.31-2.83-3.42-0.62-1.236.55-5.79-4.410.41-0.09
EPS (Weighted Average and Diluted) (Quarter) 0.00-5.31-2.83-3.42-0.62-1.796.55-3.98-4.41-0.77-0.09
Shares Outstanding (Weighted Average) (Quarter) 357.12M600.60M156.08M969.36M0.04M1,496.00M0.86M0.98M0.83M1.30M1.58M1.53M1.05M2.25M3.39M5.41M
Shares Outstanding (Diluted Average) (Quarter) 981.64M1,496.00M0.77M0.84M0.83M1.30M1.44M1.53M1.62M2.25M4.54M4.06M
EBITDA (Quarter) -5.54M-4.10M-3.34M-2.47M-0.22M-3.23M11.07M-7.82M-9.86M2.43M-0.35M
Tax Rate (Quarter) 0.63%0.76%-0.59%3.78%14.11%-0.60%-0.73%-2.21%0.35%-1.90%6.44%